Towards this goal, we identified genes that are affected by knockdown of HOXC4 and/or HOXC6 in 22Rv1 prostate cancer cells and performed ChIP-seq to characterize their genome-wide binding profiles. This evidence concerns the gene HOXC4 and prostate cancer.